Cryptococcal Meningitis – Comprehensive Medical Guide
Overview
Cryptococcal meningitis is a severe infection of the membranes (meninges) surrounding the brain and spinal cord caused by the fungus Cryptococcus neoformans (and less commonly C. gattii). The organism enters the bloodstream, crosses the blood‑brain barrier, and leads to inflammation of the meninges.
- Who it affects: Primarily individuals with weakened immune systems—especially people living with HIV/AIDS, organ‑transplant recipients, patients on long‑term corticosteroids or other immunosuppressants, and those with malignancies such as leukemia. It can also occur in apparently healthy adults, particularly in tropical/subtropical regions where C. gattii is endemic.
- Prevalence: In 2022, the World Health Organization estimated ~220,000 new cases of cryptococcal disease worldwide, with >180,000 deaths, the majority being meningitis in people with advanced HIV infection. In the United States, ≈1,000–1,200 cases are reported each year, most in patients with CD4 counts <100 cells/µL.1
- Geographic distribution: Higher incidence in sub‑Saharan Africa, Southeast Asia, and South America where HIV prevalence is high. In temperate climates, most cases are linked to immunosuppression rather than environmental exposure.
Symptoms
Symptoms develop gradually over days to weeks and may be subtle early on. The classic triad of meningitis—headache, fever, and neck stiffness—appears in only about 40 % of patients.
- Headache: Persistent, often worsening; described as pressure‑like.
- Fever: Low‑grade to high; may be absent in immunocompromised hosts.
- Neck stiffness (nuchal rigidity): Resistance to passive neck flexion.
- Photophobia: Sensitivity to light.
- Altered mental status: Confusion, lethargy, or decreased responsiveness.
- Vomiting or nausea: Due to increased intracranial pressure.
- Visual changes: Blurred vision, double vision, or loss of vision from raised intracranial pressure.
- Seizures: More common in advanced disease.
- Hearing loss: Occasionally reported.
- Skin lesions: Painless, raised, pearl‑white papules (especially in disseminated disease).
- Weight loss, fatigue, and night sweats: Non‑specific systemic signs.
Causes and Risk Factors
How the infection occurs
The fungus is found worldwide in soil contaminated with bird (especially pigeon) droppings, decaying wood, and certain trees. Infection usually starts when inhaled spores or yeast cells reach the lungs. In healthy people the infection may be cleared or remain dormant; in immunocompromised individuals it can spread hematogenously to the central nervous system (CNS).
Key risk factors
- Advanced HIV infection: CD4 count <100 cells/µL carries the highest risk. Approximately 70 % of cryptococcal meningitis cases worldwide are linked to HIV.2
- Organ transplantation: Especially within the first 6–12 months post‑transplant when immunosuppression is greatest.
- Long‑term corticosteroid or cytotoxic therapy: For autoimmune disease, malignancy, or asthma.
- Primary immunodeficiencies: e.g., IgG subclass deficiency, CARD9 deficiency.
- Chronic lung disease: COPD or prior pulmonary cryptococcosis can predispose to CNS spread.
- Geographic exposure: Living near or working with bird droppings, especially in endemic areas for C. gattii (e.g., Pacific Northwest, parts of Australia).
Diagnosis
Early recognition is crucial; diagnosis combines clinical suspicion with laboratory testing.
Initial work‑up
- Physical exam: Look for meningeal signs, papilledema, focal neurologic deficits.
- Basic labs: CBC, CMP, HIV viral load/CD4 count (if status unknown).
Definitive tests
- Lumbar puncture (LP): Cornerstone of diagnosis.
- Opening pressure is often markedly elevated (>250 mm H₂O).
- CSF analysis typically shows:
- Elevated protein (often >100 mg/dL).
- Low glucose (<40 mg/dL) relative to serum.
- Predominantly lymphocytic pleocytosis (but may be neutrophilic early).
- CSF cryptococcal antigen (CrAg) test – rapid, highly sensitive (>95 %).
- India ink stain – visualizes encapsulated yeast (sensitivity ≈70 %).
- Fungal culture – gold standard but takes 3–7 days.
- Serum cryptococcal antigen: Positive in >90 % of cases; useful for screening high‑risk HIV patients.
- Imaging: Head CT or MRI before LP if signs of raised intracranial pressure, focal deficits, or immunocompromise. Findings may include dilated ventricles, cryptococcomas, or hydrocephalus.
- Histopathology (rare): Tissue biopsy from skin lesions or lung nodules may aid diagnosis when CSF is unavailable.
Treatment Options
Therapy has three phases: induction, consolidation, and maintenance. Prompt treatment reduces mortality from >60 % to <30 % in HIV‑related disease.3
Induction Phase (first 2 weeks)
- Amphotericin B + flucytosine: Standard of care.
- Amphotericin B deoxycholate 0.7–1.0 mg/kg IV daily (or lipid formulations to reduce nephrotoxicity).
- Flucytosine 100 mg/kg/day PO divided q6h (adjust for renal function).
- If flucytosine unavailable or contraindicated, use Amphotericin B + high‑dose fluconazole (800–1200 mg/day).
- Therapeutic lumbar punctures may be performed daily to lower opening pressure >250 mm H₂O, which improves outcomes.
Consolidation Phase (8 weeks)
- Fluconazole 400–800 mg PO daily (or IV if unable to take orally).
- Continue for at least 8 weeks after CSF cultures are sterile.
Maintenance (Secondary Prophylaxis) – ≥12 months
- Fluconazole 200 mg PO daily. In HIV patients, continue until CD4 >200 cells/µL for >3 months and serum CrAg is negative.
Special considerations
- Pregnancy: Lipid formulation Amphotericin B is preferred; avoid flucytosine.
- Renal/hepatic dysfunction: Dose‑adjust amphotericin formulations and fluconazole accordingly; monitor electrolytes, creatinine, and liver enzymes.
- Drug interactions: Fluconazole inhibits CYP3A4 – adjust doses of warfarin, cyclosporine, certain antiretrovirals, and statins.
Living with Cryptococcal Meningitis
Daily management tips
- Medication adherence: Keep a pill box, set alarms, and involve a caregiver for supervised dosing.
- Monitor intracranial pressure: If you develop worsening headache, visual changes, or nausea, inform your clinician—repeat lumbar puncture may be needed.
- Hydration: Adequate fluids help renal clearance of amphotericin and reduce nephrotoxicity.
- Nutrition: High‑protein diet supports immune recovery; consider a dietitian if weight loss is significant.
- Follow‑up labs: Regular CBC, renal and liver panels; CD4 count and HIV viral load for HIV‑positive patients.
- Vaccinations: Stay up‑to‑date on pneumococcal, influenza, and COVID‑19 vaccines (non‑live) to prevent secondary infections.
- Safety: Avoid activities that could cause head trauma while intracranial pressure is elevated.
- Support: Join patient support groups (e.g., AIDS Foundation, transplant community) for emotional help and practical advice.
Prevention
- Screen high‑risk HIV patients: Serum CrAg testing for CD4 <100 cells/µL; pre‑emptive fluconazole if positive (as per WHO guidelines).4
- Environmental avoidance: Limit exposure to bird droppings, decaying wood, and soil in endemic areas, especially for immunocompromised individuals.
- Optimize immune status:
- Early initiation and adherence to antiretroviral therapy (ART) for HIV.
- Minimize immunosuppressive drug dose when possible; use prophylactic antifungals if long‑term steroids are required.
- Prophylactic antifungal therapy: Fluconazole 200 mg weekly in patients with prior cryptococcal disease or those with persistent severe immunosuppression.
Complications
If not promptly treated, cryptococcal meningitis can lead to serious, sometimes irreversible complications:
- Increased intracranial pressure (ICP): May cause vision loss, hearing loss, or herniation.
- Cerebral infarction or hemorrhage: Due to vasculitis or pressure effects.
- Cryptococcomas: Focal mass lesions that may require neurosurgical intervention.
- Hydrocephalus: Requires shunt placement in severe cases.
- Persistent neurological deficits: Cognitive impairment, gait disturbances, or seizures.
- Systemic dissemination: To lungs, skin, bones, or bloodstream (cryptococcemia).
- Relapse: Particularly if maintenance therapy is stopped early or immune recovery is inadequate.
When to Seek Emergency Care
Call 911 or go to the nearest emergency department immediately if you experience any of the following:
- Sudden severe headache that “won’t go away.”
- Vomiting + neck stiffness or photophobia.
- Rapid change in mental status—confusion, drowsiness, inability to stay awake.
- New weakness, numbness, or difficulty speaking.
- Sudden vision changes or double vision.
- Seizure activity, even if it lasts only a few seconds.
- Persistent fever (>38.5 °C) that does not improve with antipyretics.
References: